scispace - formally typeset
N

Norman S. Namerow

Researcher at University of California, Los Angeles

Publications -  31
Citations -  1508

Norman S. Namerow is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Multiple sclerosis & Somatosensory system. The author has an hindex of 20, co-authored 31 publications receiving 1479 citations. Previous affiliations of Norman S. Namerow include Freeman Hospital & Oklahoma State University Center for Health Sciences.

Papers
More filters
Journal ArticleDOI

Multiple Sclerosis: Association with HL—A3

TL;DR: The incidence of HL—A3 among 94 patients with a diagnosis of multiple sclerosis (MS) was significantly higher than for 871 normal persons, and some increase in Te58 and decrease in HL-A2 and Te60 frequencies was noted.
Journal ArticleDOI

Normative data stratified by age and education for the Neuropsychological Screening Battery for Hispanics (NeSBHIS): Initial report.

TL;DR: Normative data on a sample of 300 Hispanic subjects stratified by gender, age, and education are provided, and results reveal that not one measure of cognitive functioning is free from education effects.
Journal ArticleDOI

Somatosensory evoked responses in multiple sclerosis patients with varying sensory loss

Norman S. Namerow
- 01 Dec 1968 - 
TL;DR: It has been previously shown and confirmed in the own laboratory that the somatosensory evoked response is abnormal in disease states in which there is impairment of position or vibration sense or both, and it was felt appropriate to use this type of evoked responded as a means of assessing subcortical conduction phenomena in patients.
Journal ArticleDOI

The orbicularis oculi reflex in multiple sclerosis.

Norman S. Namerow, +1 more
- 01 Dec 1970 - 
TL;DR: While several previous studies have demonstrated changes in this reflex with various pontine lesions, only one has dealt specifically with multiple sclerosis and it was anticipated that continued study of such a relatively simple pathway would further the understanding of the nature of neuronal conduction in human demyelinating disease.